Fingerprint
Dive into the research topics where Urology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
-
Nihal Mohamed
- Institute for Health Equity Research
- Center for Scientific Workforce Excellence and Advancement
- Cancer Prevention & Control
- Icahn School of Medicine at Mount Sinai
- Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai
- Mount Sinai Tisch Cancer Center
- Urology
Person: Academic
Research output
-
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274☆
Galsky, M. D., Gschwend, J. E., Milowsky, M. I., Schenker, M., Valderrama, B. P., Tomita, Y., Bamias, A., Lebret, T., Shariat, S. F., Park, S. H., Agerbaek, M., Jha, G., Stenner, F., Ye, D., Giudici, F., Connors, J., Gupta, S., Chhibber, A., Zhang, J. & Bajorin, D. F. & 1 others, , Jan 2026, In: Annals of Oncology. 37, 1, p. 69-78 10 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
McKay, R. R., Pal, S., Xie, W., Aggen, D., Albiges, L., Apolo, A., Atkins, M. B., Bangs, R., Beckermann, K. E., Bellmunt, J., Berg, S. A., Bilen, M. A., Braun, D., Carlo, M. I., Efstathiou, J., Galsky, M., Grivas, P., Gupta, S., Haas, N. & Hakimi, A. A. & 34 others, , 1 Jan 2026, In: Ca-A Cancer Journal for Clinicians. 76, 1, e70052.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
A Practical Phenotyping Framework for Male Lower Urinary Tract Symptoms Using Remote Multi-day Urinary Diagnostics
Watts, J., Godelfer, D., Knoedler, J., Sturdy, A., Kaplan, S. & Sobol, I., 2026, (Accepted/In press) In: Urology.Research output: Contribution to journal › Article › peer-review
Open Access -
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial
Galsky, M. D., Mantia, C., Bowden, M., Bellmunt, J., Garmezy, B., Iyer, G., Petrylak, D. P., Rasco, D., Gupta, S., Rodriguez-Rivera, I., Mikhailov, Y., Joshi, A., Nguyen, P. A., Kakrecha, B., Tepper, J., Costa, A. M., McCrone, C., Rossi, A. P., Mertz, J. A. & Gjini, E. & 3 others, , Apr 2026, In: Nature Medicine. 32, 4, p. 1249-1256 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Association between psychiatric morbidity and postoperative readmission following gender-affirming vaginoplasty
Callahan, D. M., Ramsay, A., Karim, S., Shamamian, P., Safer, J. & Purohit, R. S., 2026, (Accepted/In press) In: International Journal of Transgender Health.Research output: Contribution to journal › Article › peer-review
-
A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives
Bertrand, C., Ouzaid, I., Guerrero-Ramos, F., Marcq, G., Sfakianos, J. P., Xylinas, E. & Gabriel, P. E., Dec 2026, In: World Journal of Urology. 44, 1, 44.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Benign Prostatic Hyperplasia
Kaplan, S. A., 1 Jan 2026, In: Journal of Urology. 215, 1, p. 94-96 3 p.Research output: Contribution to journal › Article › peer-review
-
Benign Prostatic Hyperplasia
Kaplan, S. A., 2026, In: Journal of Urology. Publish Ahead of PrintResearch output: Contribution to journal › Article › peer-review
-
Characteristics associated with first anti-seizure medication prescribed in a cohort of adults with newly diagnosed epilepsy
Blank, L. J., Morgenstern, R., Boockvar, K., Mohamed, N. & Jetté, N., Mar 2026, In: Seizure. 136, p. 60-65 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
ChatGPT Health performance in a structured test of triage recommendations
Ramaswamy, A., Tyagi, A., Hugo, H., Jiang, J., Jayaraman, P., Jangda, M., Te, A. E., Kaplan, S. A., Lampert, J., Freeman, R., Gavin, N., Tewari, A. K., Sakhuja, A., Naved, B., Charney, A. W., Omar, M., Gorin, M. A., Klang, E. & Nadkarni, G. N., 2026, (Accepted/In press) In: Nature Medicine.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Circadian rhythm-related miR-6883-5p suppresses enzalutamide-resistant prostate cancer
Yue, W., Li, C., Wang, T., You, J., Sun, J., Liu, J., Tewari, A. K., Natasha, K., Figueiro, M. G., Hou, J. & Padanilam, B. J., Feb 2026, In: Non-coding RNA Research. 16, p. 21-31 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Circulating Plasma and Urine Tumor DNA in Non–muscle-invasive Bladder Cancer: A Promising Biomarker to Guide Therapeutic Intensification
Gabriel, P. E., Marcq, G., Zhu, A., Sfakianos, J. P. & Xylinas, E., 2026, (Accepted/In press) In: European Urology Open Science.Research output: Contribution to journal › Letter › peer-review
Open Access
Press/Media
-
Software companies see 8.8pc drop in enterprise value amid AI fears
Kaplan,, S.
8/05/26
1 item of Media coverage
Press/Media
-
Merck & Co., Inc. (NYSE:MRK) drifts lower 0.7% in Week 18 of 2026: Latest News and Company Communication
8/05/26
1 item of Media coverage
Press/Media
-
-
The Lincoln Private Market Index: Broader Private Market Trends Were Stable Despite Software-Driven Decline; Accelerated pace of AI developments led to a bifurcated Q1 with software and highly AI impacted companies' enterprise values and loans seeing mean
Kaplan,, S.
7/05/26
16 items of Media coverage
Press/Media
-
Researchers at Icahn School of Medicine at Mount Sinai Describe Findings in Prostate Cancer (Deep-learning computer-aided detection and classification of prostate lesions on biparametric MRI: comparison with expert readers)
Lewis, S., Taouli, B., Bane, O. & Tewari, A.
4/05/26
1 item of Media coverage
Press/Media
-
Huntington Bancshares Incorporated (NASDAQ:HBAN) ticks up 1.4% in Week 17 of 2026: Latest News and Company Communication
Kapoor,, D.
4/05/26
1 item of Media coverage
Press/Media
-
Merck & Co., Inc. (NYSE:MRK) edges up 0.3% in Week 17 of 2026: Latest News and Company Communication
1/05/26
1 item of Media coverage
Press/Media
-
Crossover firms doubled down on pre-IPO bets in Q1, with deal value hitting a record $220.9B
Kaplan,, S.
30/04/26
1 item of Media coverage
Press/Media
-
Recent Findings from Alec Zhu and Co-Authors Yields New Data on Prostate Cancer (Intersection of Phenotypic Plasticity and Anoikis Enhances Therapeutic Vulnerability in Prostate Cancer)
Mehrazin,, R., Kyprianou, N. & Tewari, A.
28/04/26
1 item of Media coverage
Press/Media
-
Merck & Co., Inc. (NYSE:MRK) slides 6.1% in Week 16 of 2026: Latest News and Company Communication
24/04/26
1 item of Media coverage
Press/Media
-
Huntington Bancshares Incorporated (NASDAQ:HBAN) slips 2.7% in Week 16 of 2026: Latest News and Company Communication
Kapoor,, D.
24/04/26
1 item of Media coverage
Press/Media
-
SAS walks back pledge to go public, creates space for Goodnight succession options
Kaplan,, S.
1/04/26 → 22/04/26
4 items of Media coverage
Press/Media